| 缩写名/全名 |
ENDOCR METAB IMMUNE
Endocrine Metabolic & Immune Disorders-Drug Targets |
||||||||||||||||||||
| ISSN号 | 1871-5303 | ||||||||||||||||||||
| 研究方向 | ENDOCRINOLOGY & METABOLISMIMMUNOLOGY-IMMUNOLOGY | ||||||||||||||||||||
| 影响因子 | 2015:1.987, 2016:1.897, 2017:2.013, 2018:1.104, 2019:1.973, | ||||||||||||||||||||
| 出版国家 | U ARAB EMIRATES | ||||||||||||||||||||
| 出版周期 | |||||||||||||||||||||
| 年文章数 | 134 | ||||||||||||||||||||
| 出版年份 | 0 | ||||||||||||||||||||
| 是否OA | No | ||||||||||||||||||||
| 审稿周期(仅供参考) | |||||||||||||||||||||
| 录用比例 | |||||||||||||||||||||
| 投稿链接 | http://bsp-cms.eurekaselect.com/index.php/CDTIEMD | ||||||||||||||||||||
| 投稿官网 | http://benthamscience.com/journal/index.php?journalID=emiddt | ||||||||||||||||||||
| h-index | 44 | ||||||||||||||||||||
| CiteScore |
|
||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1871-5303%5BISSN%5D | ||||||||||||||||||||
| 中科院SCI期刊分区 （ 2018年新版本） |
|
||||||||||||||||||||
| 中科院SCI期刊分区 （ 2020年新版本） |
|
| 中国学者近期发表的论文 | |
| 1. | Testicular injury attenuated by rapamycin through induction of autophagy and inhibition of endoplasmic reticulum stress in streptozotocin-induced diabetic rats. Author: Shi W1, Guo Z2, Yuan R1. Journal: Endocr Metab Immune Disord Drug Targets. 2019 Jan 1. doi: 10.2174/1871530319666190102112844. [Epub ahead of print] PubMed DOI |
| 2. | B Lymphocytes Are Predictors of Insulin Resistance in Women with Gestational Diabetes Mellitus. Author: Zhuang Y1, Zhang J1, Li Y1, Gu H1, Zhao J1, Sun Y1, Wang R1, Zhang C1,2, Chen W1,3, Weng J1, Qi L1, Lu H1, Zhang J1, Liu Q4, He Y1, Xu X1. Journal: Endocr Metab Immune Disord Drug Targets. 2019;19(3):358-366. doi: 10.2174/1871530319666190101130300. PubMed DOI |
| 3. | New advances of ICG angiography in parathyroid identification. Author: Jin H1, Cui M1. Journal: Endocr Metab Immune Disord Drug Targets. 2019 Feb 6. doi: 10.2174/1871530319666190206212456. [Epub ahead of print] PubMed DOI |
| 4. | Silibinin ameliorates fructose-induced lipid accumulation and activates autophagy in HepG2 Cells. Author: Li Y1, Ren L2, Song G2, Zhang P1, Yang L1, Chen X1, Yu X3, Chen S2. Journal: Endocr Metab Immune Disord Drug Targets. 2019 Feb 7. doi: 10.2174/1871530319666190207163325. [Epub ahead of print] PubMed DOI |
| 5. | Exploration of the Effect and Mechanism of ShenQi Compound in a Spontaneous Diabetic Rat Model. Author: Liu Y1, Kang J1, Gao H1, Zhang X1, Chao J1, Gong G1, Yuan H1, Xie C1. Journal: Endocr Metab Immune Disord Drug Targets. 2019 Feb 24. doi: 10.2174/1871530319666190225113859. [Epub ahead of print] PubMed DOI |
| 6. | Dysregulated Interleukin -33/ST2 Pathway Perpetuate Chronic Inflammation in Hashimoto's Thyroiditis. Author: Wang X1, Shao X2, Liu X3, Qin Q2, Xu J2, Zhang JA4. Journal: Endocr Metab Immune Disord Drug Targets. 2019 Feb 26. doi: 10.2174/1871530319666190226164309. [Epub ahead of print] PubMed DOI |
| 7. | The mechanism of miR-192 in regulating high glucose-induced MCP-1 expression in rat glomerular mesangial cells. Author: Chen F1, Wei G2, Zhou Y3, Ma X1, Wang Q4. Journal: Endocr Metab Immune Disord Drug Targets. 2019 Mar 1. doi: 10.2174/1871530319666190301154640. [Epub ahead of print] PubMed DOI |
| 8. | Liraglutide Exerts Potential Anti-inflammatory Effect in Type 1 Diabetes by Inhibiting IFN-γ Production via Suppressing JAK-STAT Pathway. Author: Zhao Y1, Xie Y1, Li W1. Journal: Endocr Metab Immune Disord Drug Targets. 2019 Feb 28. doi: 10.2174/1871530319666190301115654. [Epub ahead of print] PubMed DOI |
| 9. | Impaired myocardial MIF/AMPK activation aggravates myocardial ischemia reperfusion injury in high-fat diet-induced obesity. Author: Meng F1, Li D2, Song B3, Li L2. Journal: Endocr Metab Immune Disord Drug Targets. 2019 Mar 26. doi: 10.2174/1871530319666190326143254. [Epub ahead of print] PubMed DOI |
|
|
